vialroom

#cagrilintide 2024-11-02

Saturday11 messages4 participantstimes are UTC
Highlights from this day
  • taper_or_not — monotherapy was underwhelming for me and i say that as someone who wanted it to work 22:29
  • taper_or_not — the fullness thing is the part people describe differently, food stops being interesting rather than repellent, happy to be corrected 22:31
  • taper_or_not — nobody should copy my schedule, im describing it because people asked what a slow ramp looks like 22:42
  • triple_ag_tom — right so REDEFINE is the phase 3 programme, most of what gets quoted casually in here is earlier work 22:45
  • triple_ag_tom — i said earlier this year that monotherapy did nothing for me, and at a higher dose it did something 22:59
TO

monotherapy was underwhelming for me and i say that as someone who wanted it to work

Cited study
Efficacy and Safety of Cagrilintide in Adults with Overweight or Obesity — Phase 2
The Lancet · 2021
Cagrilintide monotherapy, dose ranging. The combination trials came later.

the fullness thing is the part people describe differently, food stops being interesting rather than repellent, happy to be corrected

TO

nobody should copy my schedule, im describing it because people asked what a slow ramp looks like

REDEFINE is the trial

TA

right so REDEFINE is the phase 3 programme, most of what gets quoted casually in here is earlier work

📈1🧊1
TA

i said earlier this year that monotherapy did nothing for me, and at a higher dose it did something